T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency

AIDS Research and Human Retroviruses

Volumn 27, Issue 3, 2011, Pages 289-294

  Chen, Jun ^a   Sun, Jianjun ^a   Zhang, Renfang ^a   Liu, Li ^a   Zheng, Yufang ^a   Shen, Yinzhong ^a   Wang, Zhenyan ^a   Sun, Fuyan ^a   Li, Li ^a   Lu, Hongzhou ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSPOT ASSAY; EVALUATION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM SMEAR; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

EID: 79952605815     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0062     Document Type: Article

References (39)

1. WHO: Global tuberculosis control: Surveillance, planning, financing. WHO report 2008. WHO, Geneva, Switzerland, 2008
2. WHO: Global tuberculosis control. Epidemiology, strategy, financing. WHO, Geneva, Switzerland, 2009.
3. Antonucci G, Girardi E, Raviglione MC, and Ippolito G.: Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA 1995;274(2):143-148.
4. Barnes PF, Bloch AB, Davidson PT, and Snider DE Jr: Tu-berculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324(23):1644-1650.
5. Jiang X, Lu H, Zhang Y, et al.: A cross-sectional study of HIV and tuberculosis coinfection cases in mainland China. South Med J 2008;101(9):914-917.
6. Kingkaew N, Sangtong B, Amnuaiphon W, et al.: HIV-associated extrapulmonary tuberculosis in Thailand: Epide-miology and risk factors for death. Int J Infect Dis 2009;13(6): 722-729.
7. Pai M, Zwerling A, and Menzies D: Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: An update. Ann Intern Med 2008;149(3):177-184.
8. Chou CH, Hsu HL, Lee LN, Hsueh PR, and Luh KT: Com-parison of 2 interferon-gamma assays and Roche Cobas Amplicor Mycobacterium tuberculosis assay for rapid di-agnosis of tuberculosis among patients with suspected tuberculosis in Taiwan. J Microbiol Immunol Infect 2009; 42 (3):251-257
9. Dewan PK, Grinsdale J, and Kawamura LM: Low sensitivity of a whole-blood interferon-gamma release assay for detec-tion of active tuberculosis. Clin Infect Dis 2007;44(1): 69-73 (Pubitemid 44968987)
10. Dosanjh DP, Hinks TS, Innes JA, et al.: Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008; 148(5):325-336. (Pubitemid 351665463)
11. Goletti D, Carrara S, Butera O, et al.: Accuracy of immuno-diagnostic tests for active tuberculosis using single and combined results: A multicenter TBNET-Study. PLoS One 2008;3(10):e3417.
12. Janssens JP: Interferon-gamma release assay tests to rule out active tuberculosis. Eur Respir J 2007;30(1):183-184; author reply 184-185.
13. Kang YA, Lee HW, Hwang SS, et al.: Usefulness of whole-blood interferon-gamma assay and interferon-gamma enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007;132(3):959-965.
14. Mazurek GH, Weis SE, Moonan PK, et al.: Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis. Clin Infect Dis 2007;45(7):837-845. (Pubitemid 47580374)
15. Pai M and Menzies D: Interferon-gamma release assays: What is their role in the diagnosis of active tuberculosis? Clin Infect Dis 2007;44(1):74-77. (Pubitemid 44968988)
16. Aabye MG, Ravn P, PrayGod G, et al.: The impact of HIV infection and CD4 cell count on the performance of an in-terferon gamma release assay in patients with pulmonary tuberculosis. PLoS One 2009;4(1):e4220.
17. Karam F, Mbow F, Fletcher H, et al.: Sensitivity of IFN-gamma release assay to detect latent tuberculosis infection is retained in HIV-infected patients but dependent on HIV/AIDS progression. PLoS One 2008;3(1):e1441.
18. Leidl L, Mayanja-Kizza H, Sotgiu G, et al.: Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV-infection. Eur Respir J 2010;35(3):619-626.
19. Mandalakas AM, Hesseling AC, Chegou NN, et al.: High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 2008;12(4):417-423. (Pubitemid 351507255)
20. Stephan C, Wolf T, Goetsch U, et al.: Comparing Quanti-FERON-tuberculosis gold, T-SPOT tuberculosis and tubercu-lin skin test in HIV-infected individuals from a low prevalence tuberculosis country. AIDS 2008;22(18):2471-2479.
21. Vincenti D, Carrara S, Butera O, et al.: Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tu-berculosis: A pilot study. Clin Exp Immunol 2007;150(1):91-98. (Pubitemid 47383295)
22. Andersen P, Munk ME, Pollock JM, and Doherty TM: Spe-cific immune-based diagnosis of tuberculosis. Lancet 2000; 356(9235):1099-1104.
23. Hammond AS, McConkey SJ, Hill PC, et al.: Mycobacterial T cell responses in HIV-infected patients with advanced im-munosuppression. J Infect Dis 2008;197(2):295-299. (Pubitemid 351263451)
24. Lawn SD, Bangani N, Vogt M, et al.: Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis 2007;7:99.
25. Clark SA, Martin SL, Pozniak A, et al.: Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clin Exp Im-munol 2007;150(2):238-244. (Pubitemid 47609557)
26. Dheda K, Lalvani A, Miller RF, et al.: Performance of a T-cell-based diagnostic test for tuberculosis infection in HIV-infected individuals is independent of CD4 cell count. AIDS 2005;19(17):2038-2041. (Pubitemid 41669032)
27. Talati NJ, Seybold U, Humphrey B, et al.: Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009;9:15.
28. Richeldi L, Losi M, D'Amico R, et al.: Performance of tests for latent tuberculosis in different groups of immunocompro-mised patients. Chest 2009;136(1):198-204.
29. Hoffmann M, Reichmuth M, Fantelli K, et al.: Conventional tuberculin skin testing versus T-cell-based assays in the di-agnosis of latent tuberculosis infection in HIV-positive pa-tients. AIDS 2007;21(3):390-392. (Pubitemid 46175062)
30. Beffa P, Zellweger A, Janssens JP, Wrighton-Smith P, and Zellweger JP: Indeterminate test results of T-SPOT.TB per-formed under routine field conditions. Eur Respir J 2008; 31(4):842-846.
31. Jiang W, Shao L, Zhang Y, et al.: High-sensitive and rapid detection of Mycobacterium tuberculosis infection by IFN-gamma release assay among HIV-infected individuals in BCG-vaccinated area. BMC Immunol 2009;10:31.
32. Kampmann B, Whittaker E, Williams A, et al.: Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J 2009;33(6):1374-1382.
33. Elliott JH, Vohith K, Saramony S, et al.: Immunopathogenesis and diagnosis of tuberculosis and tuberculosis-associated immune reconstitution inflammatory syndrome during early antiretroviral therapy. J Infect Dis 2009;200(11):1736-1745.
34. Bourgarit A, Carcelain G, Martinez V, et al.: Explosion of tuberculin-specific Th1-responses induces immune restora-tion syndrome in tuberculosis and HIV co-infected patients. AIDS 2006;20(2):F1-7.
35. Day CL, Mkhwanazi N, Reddy S, et al.: Detection of poly-functional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons. J Infect Dis 2008;197(7):990-999. (Pubitemid 351590027)
36. Lawn SD, Little F, Bekker LG, et al.: Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS 2009;23(3):335-342.
37. Badri M, Wilson D, and Wood R Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study. Lancet 2002;359(9323):2059-2064. (Pubitemid 34680968)
38. Vitek E, Gusseinova N, Laricheva N, et al.: Factors associated with positive tuberculin skin test results among HIV-infected persons in Orel Oblast, Russia. Int J Tuberc Lung Dis 2009;13(7):829-835.
39. Harries AD, Maher D, and Nunn P: An approach to the problems of diagnosing and treating adult smear-negative pul-monary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ 1998;76(6):651-662. (Pubitemid 29143879)